Table 3.
Conditional logistic regression analysis of TG level and ischemic stroke
| Univariable analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| TG (mg/dLmmol/L) | 1.0122 | 1.003–1.0244 | 0.024 | 1.0120 | 1.001–1.0242 | 0.0325 |
| BMI | 1.06 | 1.01–1.12 | 0.032 | 1.05 | 0.99–1.11 | 0.089132 |
| SBP | 1.01 | 0.99–1.02 | 0.066 | 1.00 | 0.99–1.02 | 0.56216 |
| DBP | 1.02 | 1.00–1.04 | 0.020 | 1.01 | 0.99–1.03 | 0.14780 |
| CHA2DS2-VASc score | ||||||
| Low/medium risk (≤ 1) | Reference | – | – | Reference | – | – |
| High risk (≥ 2) | 1.66 | 0.78–3.51 | 0.187 | 1.327 | 0.602–2.938 | 0.49036 |
| HAS-BLED score | ||||||
| Low risk (< 3) | Reference | – | – | Reference | – | – |
| High risk (≥ 3) | 1.11 | 0.73–1.69 | 0.637 | 0.991.01 | 0.635–1.56 | 0.9750 |
| NOAC | 0.19 | 0.04–0.79 | 0.022 | 0.20 | 0.05–0.84 | 0.029 |
| LDL-C (mg/dL) | 1.01 | 0.99–1.02 | 0.318 | 1.01 | 0.99–1.02 | 0.426 |
| HDL-C (mg/dL) | 1.02 | 0.99–1.04 | 0.163 | 1.03 | 1.00–1.05 | 0.025 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; NOAC, new oral anticoagulant; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol